下一代基于抗体的癌症治疗:抗体-药物偶联物和双特异性抗体在血液系统恶性肿瘤和实体瘤中的应用 Next-generation antibody-based therapeutics in cancer: antibody-drug conjugates bispecific antibodies across hematologic malignancies and solid tumors PubMed 2026/09/09 发表J Hematol OncolQ1 · IF 47.8(JCR 2025) 靶点:CD19靶点:CD20靶点:BCMA技术:CAR-T技术:双特异性抗体急性淋巴细胞白血病多发性骨髓瘤B细胞淋巴瘤
CAR-T 疗法治疗中枢神经系统肿瘤的进展 Advances in CAR-T therapy for central nervous system tumors. PubMed 2024/11/06 发表Biomark ResQ1 · IF 14.6(JCR 2025) 靶点:CD19靶点:GD2靶点:HER2技术:CAR-T弥漫大B细胞淋巴瘤急性淋巴细胞白血病淋巴瘤
TRX1 表达优化人 CAR-T 细胞的抗肿瘤功能并赋予其对促氧化肿瘤微环境的抵抗力 Expression of TRX1 optimizes the antitumor functions of human CAR T cells and confers resistance to a pro-oxidative tumor microenvironment. PubMed 2022/12/14 发表Front ImmunolQ1 · IF 7(JCR 2025) 靶点:HER2技术:CAR-TB细胞淋巴瘤实体瘤淋巴瘤地区:欧洲
用嵌合抗原受体工程化人 MAIT 细胞用于肿瘤免疫治疗 Engineering Human MAIT Cells with Chimeric Antigen Receptors for Cancer Immunotherapy. PubMed 2022/09/07 发表J ImmunolQ2 · IF 4(JCR 2025) 靶点:CD19靶点:HER2技术:CAR-T技术:CAR-NK技术:NK 细胞B细胞淋巴瘤乳腺癌淋巴瘤
与肿瘤免疫治疗和生物制剂相关的心脏毒性 Cardiac Toxicity Associated with Cancer Immunotherapy and Biological Drugs. PubMed 2021/09/25 发表Cancers (Basel)Q2 · IF 4.8(JCR 2025) 靶点:HER2技术:CAR-T技术:TIL非小细胞肺癌套细胞淋巴瘤头颈部肿瘤